Charting the Future of Mental Health Precision Medicine with Proteomics
Date: Jan 30, 2025
Results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD) using Olink Explore HT. This research investigated a cohort of 50 mothers diagnosed with PPD, focusing on discovering proteins that may serve as unique biomarkers for early detection and treatment.
Application focusAdvancing Precision Medicine in Inflammatory Diseases with Affinity-Based Proteomics
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting joints, entheses, and skin, and is linked to higher risks of cardiovascular disease and MASLD. These associations reflect complex inflammation-metabolism interactions, but treatment effects remain unclear.
10 Apr 2025
- Application focus
Integrating plasma proteomics to identify tuberculosis-specific diagnostic biomarkers
Using mass spectrometry, Olink’s proximity extension assay, cross-disciplinary research, and international collaboration, Dr. Schiff and team have identified protein biomarkers with high TB-specificity and demonstrated the diagnostic performance of a six-protein diagnostic panel.
05 Dec 2024
- Application focus
Using NGS-Based Proteomics to Differentiate BTK Inhibitor Response in Leukemia
This webinar will highlight a study that compares the effect of three different BTK inhibitors: ibrutinib, acalabrutinib, and zanubrutinib. Patient samples were obtained before and at various time points after treatment to identify biomarkers that could be informative of the treatment’s effects.
18 Feb 2025